Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Memantine and cholinesterase inhibitor combination therapy for Alzheimer's disease: a systematic review.

Farrimond LE, Roberts E, McShane R.

BMJ Open. 2012 Jun 11;2(3). pii: e000917. doi: 10.1136/bmjopen-2012-000917. Print 2012.

2.

EFNS-ENS/EAN Guideline on concomitant use of cholinesterase inhibitors and memantine in moderate to severe Alzheimer's disease.

Schmidt R, Hofer E, Bouwman FH, Buerger K, Cordonnier C, Fladby T, Galimberti D, Georges J, Heneka MT, Hort J, Laczó J, Molinuevo JL, O'Brien JT, Religa D, Scheltens P, Schott JM, Sorbi S.

Eur J Neurol. 2015 Jun;22(6):889-98. doi: 10.1111/ene.12707. Epub 2015 Mar 25. Review.

PMID:
25808982
3.

The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology Appraisal No. 111): a systematic review and economic model.

Bond M, Rogers G, Peters J, Anderson R, Hoyle M, Miners A, Moxham T, Davis S, Thokala P, Wailoo A, Jeffreys M, Hyde C.

Health Technol Assess. 2012;16(21):1-470. doi: 10.3310/hta16210. Review.

4.

Cost-utility analysis of memantine extended release added to cholinesterase inhibitors compared to cholinesterase inhibitor monotherapy for the treatment of moderate-to-severe dementia of the Alzheimer's type in the US.

Saint-Laurent Thibault C, Özer Stillman I, Chen S, Getsios D, Proskorovsky I, Hernandez L, Dixit S.

J Med Econ. 2015;18(11):930-43. doi: 10.3111/13696998.2015.1063501. Epub 2015 Aug 26.

PMID:
26086535
5.

Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.

Rolinski M, Fox C, Maidment I, McShane R.

Cochrane Database Syst Rev. 2012 Mar 14;(3):CD006504. doi: 10.1002/14651858.CD006504.pub2. Review.

PMID:
22419314
6.

Memantine for dementia.

Areosa SA, Sherriff F, McShane R.

Cochrane Database Syst Rev. 2005 Apr 18;(2):CD003154. Review. Update in: Cochrane Database Syst Rev. 2005;(3):CD003154.

PMID:
15846650
7.

Memantine for dementia.

Areosa SA, Sherriff F, McShane R.

Cochrane Database Syst Rev. 2005 Jul 20;(3):CD003154. Review. Update in: Cochrane Database Syst Rev. 2006;(2):CD003154.

PMID:
16034889
8.

Memantine for dementia.

McShane R, Areosa Sastre A, Minakaran N.

Cochrane Database Syst Rev. 2006 Apr 19;(2):CD003154. Review.

PMID:
16625572
9.

Memantine for dementia.

Areosa SA, Sherriff F.

Cochrane Database Syst Rev. 2003;(3):CD003154. Review. Update in: Cochrane Database Syst Rev. 2004;(4):CD003154.

PMID:
12917950
10.

Memantine for dementia.

Areosa SA, Sherriff F.

Cochrane Database Syst Rev. 2003;(1):CD003154. Review. Update in: Cochrane Database Syst Rev. 2003;(3):CD003154.

PMID:
12535459
11.

The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer's disease.

Loveman E, Green C, Kirby J, Takeda A, Picot J, Payne E, Clegg A.

Health Technol Assess. 2006 Jan;10(1):iii-iv, ix-xi, 1-160. Review.

12.

Memantine monotherapy for Alzheimer's disease: a systematic review and meta-analysis.

Matsunaga S, Kishi T, Iwata N.

PLoS One. 2015 Apr 10;10(4):e0123289. doi: 10.1371/journal.pone.0123289. eCollection 2015 Apr 10. Review.

13.

Rivastigmine for Alzheimer's disease.

Birks JS, Grimley Evans J.

Cochrane Database Syst Rev. 2015 Apr 10;(4):CD001191. doi: 10.1002/14651858.CD001191.pub3. Review.

PMID:
25858345
14.

Omega-3 fatty acids for the treatment of dementia.

Burckhardt M, Herke M, Wustmann T, Watzke S, Langer G, Fink A.

Cochrane Database Syst Rev. 2016 Apr 11;4:CD009002. doi: 10.1002/14651858.CD009002.pub3. Review.

PMID:
27063583
15.

Selegiline for Alzheimer's disease.

Birks J, Flicker L.

Cochrane Database Syst Rev. 2003;(1):CD000442. Review.

PMID:
12535396
16.

Rivastigmine for Alzheimer's disease.

Birks JS, Chong LY, Grimley Evans J.

Cochrane Database Syst Rev. 2015 Sep 22;9:CD001191. [Epub ahead of print] Review.

PMID:
26393402
18.

Combination Therapy Showed Limited Superiority Over Monotherapy for Alzheimer Disease: A Meta-analysis of 14 Randomized Trials.

Tsoi KK, Chan JY, Leung NW, Hirai HW, Wong SY, Kwok TC.

J Am Med Dir Assoc. 2016 Sep 1;17(9):863.e1-8. doi: 10.1016/j.jamda.2016.05.015. Epub 2016 Jun 24.

PMID:
27349622
19.

Systematic review and meta-analysis of combination therapy with cholinesterase inhibitors and memantine in Alzheimer's disease and other dementias.

Muayqil T, Camicioli R.

Dement Geriatr Cogn Dis Extra. 2012 Jan;2(1):546-72. doi: 10.1159/000343479. Epub 2012 Nov 23.

20.

Galantamine for Alzheimer's disease.

Olin J, Schneider L.

Cochrane Database Syst Rev. 2001;(4):CD001747. Review. Update in: Cochrane Database Syst Rev. 2002;(3):CD001747.

PMID:
11687119

Supplemental Content

Support Center